|
|
|
|
||
Re: interesting etbx trialIt appears that the numerous p1/p2 trials planned to start enrollment this year includes all Etubics and Gbim target proteins .. am not sure if this study is pre-requisite for Etubics or added support Panc cancer is exception in that it uses KRAS from Gbim and CEA from Etubics |
return to message board, top of board |